Sfoglia per Autore
Factors that affect human hemopoiesis are produced by T-cell growth factor dependent and independent cultured T-cell leukemia-lymphoma cells
1982 C. Tarella, F. Ruscetti, B. Poiesz, A. Woods, R. Gallo
Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation
1989 A. Gianni, S. Siena, M. Bregni, C. Tarella, A. C. Stern, A. Pileri, G. Bonadonna
Use of recombinant hematopoietic growth factors after chemotherapy and high-dose chemo-radiotherapy
1989 A. Gianni, M. Bregni, S. Siena, C. Tarella
GM-CSF-exposed peripheral blood progenitors as sole source of stem cells for autologous transplantation in two patients with multiple myeloma
1990 A. Pileri, C. Tarella, M. Bregni, M. Boccadoro, S. Siena, D. Caracciolo, G. Bonadonna, A.M. Gianni
Heterogeneity of circulating hematopoietic progenitors in cancer patients treated with high-dose cyclophosphamide and recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF)
1990 S. Siena, M. Bregni, F. Ravagnani, B. Brando, C. Tarella, G. Bonadonna, A. Gianni
Pharmacology and clinical toxicity of 4'-Iodo-4'-deoxydoxorubicin: an example of successful application of pharmacokinetics to dose escalation in phase 1 trials
1990 L. Gianni, L. Vigano', A. Surbone, D. Ballinari, P. Casali, C. Tarella, J. Collins, G. Bonadonna
Conditions influencing the expansion of the circulating hemopoietic progenitor cell compartment
1990 C. Tarella, D. Ferrero, S. Siena, E. Gallo, P. Bondesan, M. Bregni, A. Pileri, A. Gianni
Durable and complete hematopoietic reconstitution after autografting of rhGM-CSF exposed peripheral blood progenitor cells
1990 A.M. Gianni, C. Tarella, S. Siena, M. Bregni, M. Boccadoro, F. Lombardi, C. Bengala, G. Bonadonna, A. Pileri
Peripheral blood expansion of early progenitor cells after high-dose cyclophosphamide and rhGM-CSF
1991 C. Tarella, D. Ferrero, M. Bregni, S. Siena, E. Gallo, A. Pileri, A. M. Gianni
[Clinical use of hematopoietic growth factors]
1991 A. M. Gianni, M. Bregni, S. Siena, C. Tarella, M. DiNicola, G. Bonadonna
Granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor infusion makes high-dose etoposide a safe outpatient regimen that is effective in lymphoma and myeloma patients
1992 A. M. Gianni, M. Bregni, S. Siena, M. Magni, M. Di Nicola, F. Lombardi, C. Tarella, A. Pileri, G. Bonadonna
Role of chemotherapy and GM-CSF on hemopoietic progenitor cell mobilization in multiple myeloma
1993 C. Tarella, M. Boccadoro, P. Omedé, P. Bondesan, D. Caracciolo, R. Frieri, M. Bregni, S. Siena, A. M. Gianni, A. Pileri
Selection and characterization of early hematopoietic progenitors using an anti-CD71/S06 immunotoxin
1994 G. Benedetti, P. Bondesan, D. Caracciolo, C. Cherasco, D. Ruggieri, M. E. Gastaldi, A. Pileri, A. M. Gianni, C. Tarella
High-dose sequential chemoradiotherapy, a widely applicable regimen, confers survival benefit to patients with high-risk multiple myeloma
1994 A. M. Gianni, C. Tarella, M. Bregni, S. Siena, F. Lombardi, L. Gandola, D. Caracciolo, A. Stern, G. Bonadonna, M. Boccadoro
Durability of hematopoiesis following autografting with peripheral blood hematopoietic progenitors
1994 S. Siena, M. Bregni, M. Di Nicola, F. Ravagani, F. Peccatori, L. Gandola, F. Lombardi, C. Tarella, G. Bonadonna, A. M. Gianni
CD34-positive cells: biology and clinical relevance
1995 C.C. Stella, M. Cazzola, P. De Fabritiis, A. De Vincentiis, A.M. Gianni, F. Lanza, F. Lauria, R.M. Lemoli, C. Tarella, P. Zanon
Haematological support of high-dose sequential chemotherapy: clinical evidence for reduction of toxicity and high response rates in poor risk lymphomas
1995 C. Tarella, P. Gavarotti, D. Caracciolo, P. Corradini, C. Cherasco, C. Castellino, E. Gallo, A. Pileri
High-dose sequential chemoradiotherapy in multiple myeloma: residual tumor cells are detectable in bone marrow and peripheral blood cell harvests and after autografting
1995 P. Corradini, C. Voena, M. Astolfi, M. Ladetto, C. Tarella, M. Boccadoro, A. Pileri
Circulating progenitors following high-dose sequential (HDS) chemotherapy with G-CSF: short intervals between drug courses severely impair progenitor mobilization
1995 C. Tarella, D. Caracciolo, P. Gavarotti, P. Bondesan, C. Cherasco, P. Omedè, M. Bregni, S. Siena, A. M. Gianni, A. Pileri
Both early and committed haemopoietic progenitors are more frequent in peripheral blood than in bone marrow during mobilization induced by high-dose chemotherapy + G-CSF
1995 C. Tarella, G. Benedetti, D. Caracciolo, C. Castellino, C. Cherasco, P. Bondesan, P. Omedé, D. Ruggieri, A.M. Gianni, A. Pileri
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile